Cyclo Therapeutics : Material Event - Form 8-K -December 18, 2023 at 06:13 am EST : vimarsana.com

Item 8.01 Other Events.


Other Events


As previously announced, on September 21, 2023, Cyclo Therapeutics, Inc. and Cameo Merger Sub, Inc., a Delaware corporation...

Related Keywords

Delaware , United States , Aaron Vandevender , Tahir Mahmood , Wilson Sonsini Goodrich Rosati , Pc Wilson Sonsini , Cameo Merger Sub Inc , Rafael Holdings Inc , Clementia Pharmaceuticals , Savara Pharmaceuticals , Molecular Transport Inc , Reneo Pharmaceuticals , Kalvista Pharmaceuticals , Censa Pharmaceuticals , Alexion Pharmaceuticals , Audit Committee , Party Transaction , Audit Committee Charter , Exchange Commission , Ironwood Pharmaceuticals , Novo Nordisk , Sucampo Pharmaceuticals , Thornhill Therapeutics Inc , Exchange Ratio , Cyclo Therapeutics Inc , Comparable Companies , Cyclo Therapeutics , Cameo Merger Sub , Applied Molecular Transport Inc , Merger Agreement , Merger Sub , Current Report , Registration Statement , Joint Proxy , Summary Risk Factors Related , Factors Risk Related , Exchange Act , Wilson Sonsini Goodrich , Rafael Holdings , Nasdaq Listing Rule , May Purchase , June Purchase Agreements , Annual Meeting , Nasdaq Listing , Stockholder Equity Rule , June Purchase , Financial Advisor , Financial Projections Regarding , Cyclo Financial Analysis Selected Public Trading , Cyclo Financial Analysis Discounted Cash Flow , Relative Valuation , Pro Forma Combination Analysis , Intrinsic Valuation , Merger Consideration , Has Get Analysis , Merger Agreement Platform , Thornhill Therapeutics , Cash Amount , Net Cash Amount , Governance Guidelines , Related Party Transaction Policy , Securities Act , Proxy Statement , Markets ,